Show simple item record

2020-01-21Zeitschriftenartikel DOI: 10.2807/1560-7917.ES.2021.26.3.2000708
The European tiered approach for virucidal efficacy testing – rationale for rapidly selecting disinfectants against emerging and re-emerging viral diseases
dc.contributor.authorEggers, Maren
dc.contributor.authorSchwebke, Ingeborg
dc.contributor.authorSuchomel, Miranda
dc.contributor.authorFotheringham, Valerie
dc.contributor.authorGebel, Jürgen
dc.contributor.authorMeyer, Bernhard
dc.contributor.authorMorace, Graziella
dc.contributor.authorRoedger, Hans Joachim
dc.contributor.authorRoques, Christine
dc.contributor.authorVisa, Pilar
dc.contributor.authorSteinhauer, Katrin
dc.date.accessioned2021-01-26T10:42:56Z
dc.date.available2021-01-26T10:42:56Z
dc.date.issued2020-01-21none
dc.identifier.other10.2807/1560-7917.ES.2021.26.3.2000708
dc.identifier.urihttp://edoc.rki.de/176904/7704
dc.description.abstractWhen facing an emerging virus outbreak such as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a quick reaction time is key to control the spread. It takes time to develop antivirals and vaccines, and implement vaccination campaigns. Therefore, preventive measures such as rapid isolation of cases and identification and early quarantine of cases’ close contacts—as well as masks, physical distancing, hand hygiene, surface disinfection and air control—are crucial to reduce the risk of transmission. In this context, disinfectants and antiseptics with proven efficacy against the outbreak virus should be used. However, biocidal formulations are quite complex and may include auxiliary substances such as surfactants or emollients in addition to active substances. In order to evaluate disinfectants’ efficacy objectively, meaningful efficacy data are needed. Therefore, the European Committee for Standardisation technical committee 216 ‘Chemical disinfectants and antiseptics’ Working Group 1 (medical area) has developed standards for efficacy testing. The European tiered approach grades the virucidal efficacy in three levels, with corresponding marker test viruses. In the case of SARS-CoV-2, disinfectants with proven activity against vaccinia virus, the marker virus for the European claim ‘active against enveloped viruses’, should be used to ensure effective hygiene procedures to control the pandemic.eng
dc.language.isoengnone
dc.publisherRobert Koch-Institut
dc.rights(CC BY 3.0 DE) Namensnennung 3.0 Deutschlandger
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/de/
dc.subject.ddc610 Medizin und Gesundheitnone
dc.titleThe European tiered approach for virucidal efficacy testing – rationale for rapidly selecting disinfectants against emerging and re-emerging viral diseasesnone
dc.typearticle
dc.identifier.urnurn:nbn:de:kobv:0257-176904/7704-7
dc.identifier.doihttps://doi.org/10.2807/1560-7917.ES.2021.26.3.2000708
dc.identifier.doihttp://dx.doi.org/10.25646/7917
dc.type.versionpublishedVersionnone
local.edoc.container-titleEurosurveillancenone
local.edoc.type-nameZeitschriftenartikel
local.edoc.container-typeperiodical
local.edoc.container-type-nameZeitschrift
local.edoc.container-urlhttps://www.eurosurveillance.org/content/10.2807/1560-7917.ES.2021.26.3.2000708#html_fulltextnone
local.edoc.container-volume26none
local.edoc.container-issue3none
local.edoc.container-reportyear2020none
local.edoc.container-periodicalpart-creatorEurosurveillancenone
local.edoc.container-firstpage1none
local.edoc.container-lastpage7none
local.edoc.rki-departmentInfektionskrankheitennone
dc.description.versionPeer Reviewednone

Show simple item record